Transcriptomics

Dataset Information

0

Tumor-derived Lysophosphatidic Acid Blunts Protective Type-I Interferon Responses in Ovarian Cancer


ABSTRACT: Lysophosphatidic acid (LPA) is a bioactive lipid enriched in highly immunosuppressive neoplasms like ovarian cancer (OvCa). While LPA is known to enhance the tumorigenic capacity of malignant cells, the immunomodulatory role of this phospholipid in cancer remains largely unexplored. Here, we report that LPA operates as a negative regulator of type-I interferon (IFN) responses in OvCa. Ablation of the LPAgenerating enzyme autotaxin in OvCa cells reprogrammed the tumor immune microenvironment, extended host survival, and improved the effects of therapies that elicit protective responses driven by type-I IFN. Mechanistically, LPA sensing by dendritic cells triggered PGE2 synthesis that suppressed type-I IFN signaling via autocrine EP4 engagement. Moreover, we identified an LPA-controlled, immune-derived gene signature associated with weak responses to combined PARP inhibition and PD-1 blockade in OvCa patients. Controlling LPA production or sensing in tumors may therefore be useful to improve cancer immunotherapies that rely on robust induction of type-I IFN.

ORGANISM(S): Mus musculus

PROVIDER: GSE182062 | GEO | 2022/08/02

REPOSITORIES: GEO

Similar Datasets

2009-06-11 | GSE15263 | GEO
2011-06-01 | GSE26442 | GEO
2011-06-01 | E-GEOD-26442 | biostudies-arrayexpress
2014-05-16 | GSE56265 | GEO
2016-11-30 | E-MTAB-4648 | biostudies-arrayexpress
2014-05-12 | E-GEOD-57496 | biostudies-arrayexpress
2014-05-16 | E-GEOD-56265 | biostudies-arrayexpress
2020-06-23 | GSE153012 | GEO
2014-05-12 | GSE57496 | GEO
2014-01-10 | GSE53457 | GEO